BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 37288703)

  • 1. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
    Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
    Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome, a Rising Biomarkers in Liquid Biopsy: Advances of Label-Free and Label Strategy for Diagnosis of Cancer.
    Liu Q; Zheng J; Xie A; Chen M; Gong RY; Sheng Y; Chen HL; Qi CB
    Crit Rev Anal Chem; 2024 Apr; ():1-12. PubMed ID: 38669199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer.
    Guo W; Ying P; Ma R; Jing Z; Ma G; Long J; Li G; Liu Z
    Cytokine Growth Factor Rev; 2023 Oct; 73():69-77. PubMed ID: 37684117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in pancreatic cancer: the beginning of a new era.
    Yadav DK; Bai X; Yadav RK; Singh A; Li G; Ma T; Chen W; Liang T
    Oncotarget; 2018 Jun; 9(42):26900-26933. PubMed ID: 29928492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-targeted nanoarrays for early broad-spectrum detection of lung cancer based on blood biopsy of tumor exosomes.
    Lian S; Wang Q; Liu Y; Lu Y; Huang L; Deng H; Xie X
    Talanta; 2024 May; 276():126270. PubMed ID: 38761662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Printed Divisional Optical Biochip for Multiplex Visualizable Exosome Analysis at Point-of-Care.
    Yang X; Zhang Z; Wu Y; Wang H; Yun Y; Sun Y; Xie H; Bogdanov B; Senyushkin P; Chi J; Lian Z; Wu D; Su M; Song Y
    Adv Mater; 2024 Jan; 36(4):e2304935. PubMed ID: 37589665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphene Sensor Arrays for Rapid and Accurate Detection of Pancreatic Cancer Exosomes in Patients' Blood Plasma Samples.
    Yin T; Xu L; Gil B; Merali N; Sokolikova MS; Gaboriau DCA; Liu DSK; Muhammad Mustafa AN; Alodan S; Chen M; Txoperena O; Arrastua M; Gomez JM; Ontoso N; Elicegui M; Torres E; Li D; Mattevi C; Frampton AE; Jiao LR; Ramadan S; Klein N
    ACS Nano; 2023 Aug; 17(15):14619-14631. PubMed ID: 37470391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1.
    Jiang M; Jike Y; Liu K; Gan F; Zhang K; Xie M; Zhang J; Chen C; Zou X; Jiang X; Dai Y; Chen W; Qiu Y; Bo Z
    Mol Cancer; 2023 Jul; 22(1):113. PubMed ID: 37461104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.
    Zou Y; Zhao Z; Wang J; Ma L; Liu Y; Sun L; Song Y
    Int J Biol Sci; 2023; 19(10):3099-3114. PubMed ID: 37416779
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR/Cas13a-Based MicroRNA Detection in Tumor-Derived Extracellular Vesicles.
    Hong JS; Son T; Castro CM; Im H
    Adv Sci (Weinh); 2023 Aug; 10(24):e2301766. PubMed ID: 37340600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge mapping and research trends of exosomes in pancreatic cancer: a bibliometric analysis and review (2013-2023).
    Zhou Y; Feng J; Wang Q; Zhao Y; Ding H; Jiang K; Ji H; Tang Z; Dai R
    Front Oncol; 2024; 14():1362436. PubMed ID: 38720811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy.
    Wu Y; Han W; Dong H; Liu X; Su X
    MedComm (2020); 2024 Apr; 5(4):e541. PubMed ID: 38585234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Panorama of Extracellular Vesicle Applications: From Biomarker Detection to Therapeutics.
    Das S; Lyon CJ; Hu T
    ACS Nano; 2024 Apr; 18(14):9784-9797. PubMed ID: 38471757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology.
    Wall NR; Fuller RN; Morcos A; De Leon M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer.
    Yu Z; Yang Y; Fang W; Hu P; Liu Y; Shi J
    ACS Nano; 2023 Jun; 17(12):11384-11395. PubMed ID: 37288703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS In Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation.
    Yan S; Zheng H; Zhao J; Gao M; Zhang X
    Anal Chem; 2023 Jul; 95(27):10196-10203. PubMed ID: 37368911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fe-Au Nanoparticle-Coupling for Ultrasensitive Detections of Circulating Tumor DNA.
    Hu P; Zhang S; Wu T; Ni D; Fan W; Zhu Y; Qian R; Shi J
    Adv Mater; 2018 Aug; 30(31):e1801690. PubMed ID: 29931715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface-Enhanced Raman Scattering Substrate.
    Li J; Li Y; Chen S; Duan W; Kong X; Wang Y; Zhou L; Li P; Zhang C; Du L; Wang C
    Small Methods; 2022 Jun; 6(6):e2200154. PubMed ID: 35460217
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.